MetaCap

Lantern Pharma (LTRN) vs Processa Pharmaceuticals (PCSA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $3.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LTRN-73.08%PCSA+9.86%
+43%-18%-79%
Oct 7, 20261 yearNov 20, 2026
LTRN-69.85%PCSA+2.63%
+32%-21%-75%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LTRN versus PCSA key metrics
MetricLTRNPCSA
Share price$0.245$1.56
Market cap$3.89M$4.37M
1-day change-13.73%-7.69%
YTD return-91.91%—
1-year return-91.89%—
5-year return-97.27%—
EPS (TTM)$-1.44$-68.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-17.12M$-13.56M
52-week high$4.34$8.88
52-week low$0.2286$1.04
Distance from 52-week high-94.35%-82.43%
Analyst consensusnone—
Avg. price target upside+7042.86%—
Average volume249.66K79.50K
Shares outstanding15.89M2.80M
Employees1612
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Lantern Pharma

LTRN stock →

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.

Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees

About Processa Pharmaceuticals

PCSA stock →

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

LTRN vs PCSA FAQ

Which is bigger, Lantern Pharma or Processa Pharmaceuticals?

Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $3.89M for Lantern Pharma (LTRN).

Are Lantern Pharma and Processa Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons